Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.
Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum
Novel Applications in Oncology and Applied Sciences, Growing Research and Diagnostic Use in Developing Regions, and Automated Modular Workflows to Drive Growth
Region : North AmericaOverview: PCR continues to be the gold standard for nucleic acid amplification by combining accuracy and efficacy that users across areas such as research, pharma & biotech, diagnostics as well as applied sciences depend upon. Such widespread usage continues to drive the industry, even protecting it to some extent from overall economic/market fluct...
A Market Opportunity Assessment of Medical Imaging‘s Flourishing Contribution to Personalized Medicine Initiatives
Region : GlobalThe precision medicine paradigm has found its early roots in genetic profiling, as genomics have proven their potential in helping clinicians decide on the right treatment for the right patient at the right time. Not far behind is medical imaging, which is rapidly developing its own, image-based approaches to tailoring decisions and care pathways t...
Innovation-as-a-service Business Model will Accelerate Growth in the Molecular Diagnostic Subsegment
Region : North AmericaRapid technological turnaround has become a norm in the life science and in-vitro diagnostic industry. Extrinsic factors such as lack of skilled labor to operate the instrumentation as well as functional factors like demand for very high precision and reproducibility of results are driving this technological evolution. As the instrument efficiency ...
Emerging Use Cases, Revenue, and Industry Savings Potential
Region : North AmericaArtificial Intelligence (AI) for medical imaging is a reality now. While image analysis applications are the most advanced, adopted, and well-known, there are several other use cases which are probably not as well-known or thought of. Applications across the imaging workflow, beginning with the ordering of images by a physician, scheduling of the s...
A Robust Product Pipeline Creating Opportunities for Ground-breaking Combination Therapies to Revolutionize the Global Cell Therapy Market
Region : North AmericaThe global pharmaceuticals industry is continuously evolving to meet the requirements of a changing disease landscape. With the increasing prevalence of chronic infectious diseases and cancer, market needs are shifting from traditional small molecules to novel large molecule therapies, with cell therapies dominating the space. This study presents a...
Companies are Vying for a Higher Market Position in the Early Cancer Screening Market
Region : North AmericaLiquid biopsy (CTCs and ctDNAs) is slowly gaining momentum in clinical care given its advantages over the traditional tissue-based gold standard methods. Short-term applications in cancer care range from risk assessment to cancer recurrence monitoring. Despite the proven advantages, there is still a significant number of barriers to adoption such a...
Optimizing Quality and Efficiency of Healthcare Delivery with AI
Region : North AmericaThe study describes how AI technologies are paired with legacy healthcare IT systems to deal with the complexity & growth of medical data. Frost & Sullivan acknowledges that AI intuitively finds ways to convert these ever-expanding resources into actionable evidence for end users. In this study, Frost & Sullivan has forecast global revenue for prim...
Patent Expiries, Defined Regulatory Pathways, and Escalating Healthcare Costs to Boost Growth
Region : Asia PacificBiosimilars is a massive opportunity; regardless of a slow start, the market will eventually be a huge business. As per Frost & Sullivan’s estimate, biologic drugs worth $70–$80 billion will lose exclusivity in the next 5 years globally and APAC’s contribution would be more than 20%. Countries in the region, such as India, China, and South Ko...
New Business Models and More FDA Approvals of WSI Scanners for Primary Diagnostics are Set to Boost Growth of Digital Pathology
Region : North AmericaShortage of pathologists and the rise in new cancer cases are the key drivers for the adoption of digital pathology solutions globally. Digital pathology enhances the productivity of pathologists by 10% to 15%, thereby improving the overall efficiency of healthcare providers. Digital pathology solutions find the best fit in oncology care. Accordin...
Hospitals Investing in Health Data Continuity, Big Data, Cloud, and Data Security to Improve Patient Experience
Region : Asia PacificHospital health information technology (hospital IT) includes solutions that have a common end goal – to improve the quality of in-patient care while reducing cost. For the purpose of this report, the hospital IT market consists of software, solutions, and maintenance services but does not include hardware. The market is segmented into clinical i...